Cargando…

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension

IMPORTANCE: Chlorthalidone is currently recommended as the preferred thiazide diuretic to treat hypertension, but no trials have directly compared risks and benefits. OBJECTIVE: To compare the effectiveness and safety of chlorthalidone and hydrochlorothiazide as first-line therapies for hypertension...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hripcsak, George, Suchard, Marc A., Shea, Steven, Chen, RuiJun, You, Seng Chan, Pratt, Nicole, Madigan, David, Krumholz, Harlan M., Ryan, Patrick B., Schuemie, Martijn J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042845/ https://www.ncbi.nlm.nih.gov/pubmed/32065600 http://dx.doi.org/10.1001/jamainternmed.2019.7454

Ejemplares similares

Large-scale evidence generation and evaluation across a network of databases (LEGEND): assessing validity using hypertension as a case study
por: Schuemie, Martijn J, et al.
Publicado: (2020)

Erratum to: Large-Scale Evidence Generation and Evaluation across a Network of Databases (LEGEND): Assessing Validity Using Hypertension as a Case Study
por: Schuemie, Martijn J, et al.
Publicado: (2020)

Principles of Large-scale Evidence Generation and Evaluation across a Network of Databases (LEGEND)
por: Schuemie, Martijn J, et al.
Publicado: (2020)

Comparison of Clinical Outcomes and Safety Associated With Chlorthalidone vs Hydrochlorothiazide in Older Adults With Varying Levels of Kidney Function
por: Edwards, Cedric, et al.
Publicado: (2021)

Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison
por: Mehta, Ravi Tejraj, et al.
Publicado: (2018)

Comparative antiplatelet effects of chlorthalidone and hydrochlorothiazide
por: Bashir, Khalid, et al.
Publicado: (2022)

Pairwise comparison of hydrochlorothiazide and chlorthalidone responses among hypertensive patients
por: Chekka, Lakshmi Manasa S., et al.
Publicado: (2022)

Network meta-analysis of efficacy and safety of chlorthalidone and hydrochlorothiazide in hypertensive patients
por: Dineva, Stela, et al.
Publicado: (2020)

Comparison of the Effectiveness and Safety of Chlorthalidone and Hydrochlorothiazide in Patients With Hypertension: A Meta-Analysis
por: Khenhrani, Raja Ram, et al.
Publicado: (2023)

Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide—meta-analysis
por: Dineva, Stela, et al.
Publicado: (2019)

Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies
por: Khera, Rohan, et al.
Publicado: (2022)

Efficacy and Safety of Valsartan or Chlorthalidone vs. Combined Valsartan and Chlorthalidone in Patients With Mild to Moderate Hypertension: The VACLOR Study
por: Manzur, Fernando, et al.
Publicado: (2018)

Robust empirical calibration of p‐values using observational data
por: Schuemie, Martijn J., et al.
Publicado: (2016)

Improving reproducibility by using high-throughput observational studies with empirical calibration
por: Schuemie, Martijn J., et al.
Publicado: (2018)

Drawing Reproducible Conclusions from Observational Clinical Data with OHDSI
por: Hripcsak, George, et al.
Publicado: (2021)

Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-Analysis
por: Kumar, Lakshya, et al.
Publicado: (2023)

Combining angiotensin receptor blockers with chlorthalidone or hydrochlorothiazide – which is the better alternative? A meta-analysis
por: Filipova, Elena, et al.
Publicado: (2020)

Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study
por: Sharma, Arya M, et al.
Publicado: (2007)

A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension
por: Cushman, William C., et al.
Publicado: (2018)

Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial
por: Martins, Vítor Magnus, et al.
Publicado: (2019)

Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts
por: You, Seng Chan, et al.
Publicado: (2019)

Clinical utility of azilsartan–chlorthalidone fixed combination in the management of hypertension
por: Shuster, Jerrica E, et al.
Publicado: (2012)

Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients
por: Destro, Maurizio, et al.
Publicado: (2010)

Tailoring Chlorthalidone Aqueous Solubility by Cocrystallization: Stability and Dissolution Behavior of a Novel Chlorthalidone-Caffeine Cocrystal
por: Rodríguez-Ruiz, Christian, et al.
Publicado: (2022)

Interpreting observational studies: why empirical calibration is needed to correct p-values
por: Schuemie, Martijn J, et al.
Publicado: (2014)

Interamerican Society of Cardiology (IASC) position statement: Chlorthalidone vs. thiazide-type diuretics()
por: Pareek, Anil, et al.
Publicado: (2020)

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension
por: Marfatia, Ravi, et al.
Publicado: (2012)

Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study
por: Kereiakes, Dean J, et al.
Publicado: (2012)

Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort
por: Lu, Yuan, et al.
Publicado: (2022)

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
por: Martinez-Martin, F J, et al.
Publicado: (2011)

A plea to stop using the case‐control design in retrospective database studies
por: Schuemie, Martijn J., et al.
Publicado: (2019)

Treatment of Hypertension with Combination of Lisinopril/Hydrochlorothiazide
por: Sukalo, Aziz, et al.
Publicado: (2016)

Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER‐Prevention Randomized Clinical Trial
por: Fuchs, Sandra Costa, et al.
Publicado: (2016)

PSUN274 Chlorthalidone-Induced Diabetic Ketoacidosis.
por: Zafar, Rafia, et al.
Publicado: (2022)

Thiazide diuretics are back in CKD: the case of chlorthalidone
por: Minutolo, Roberto, et al.
Publicado: (2022)

S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial
por: Jo, Sang-Ho, et al.
Publicado: (2018)

Hydrochlorothiazide vs Venlafaxine: Drug-induced Bullous Pemphigoid
por: Naramala, Srikanth, et al.
Publicado: (2019)

Medication-Wide Association Studies
por: Ryan, P B, et al.
Publicado: (2013)

Vaccine Safety Surveillance Using Routinely Collected Healthcare Data—An Empirical Evaluation of Epidemiological Designs
por: Schuemie, Martijn J., et al.
Publicado: (2022)

Corrigendum: Vaccine safety surveillance using routinely collected healthcare data—An empirical evaluation of epidemiological designs
por: Schuemie, Martijn J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_drdb1krq1m67kpo88msddfs8ed